Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Indian pharma’s next chapter of growth depends on innovation and R&D investments
Dr Seema Singh, Assistant Professor, Campus Law Centre, University of Delhi, explains the various requirements of the Indian…
Haplo-cord treatment may offer lasting cure for over 37.7 mn HIV patients: GlobalData
However, more research will be required to assess if this is a cure as opposed to longer-term remission
Binnopharm Group to acquire two anti-bacterial brands from Dr Reddy’s
Through its affiliate Joint Stock Company, Alium, Binnopharm Group will acquire the two anti-bacterial brands Ciprolet and Levolet…
Movfor phase-III trials show positive results: Hetero
Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the…
Moderna to develop mRNA-based shingles vaccine
The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to…
Bayer lifts peak sales estimate for prostate cancer drug
The company said it now expected more than 3 billion euros ($3.4 billion) in sales from the product in its best year
BioNTech pledges African access to its future cancer drugs
BioNTech earlier unveiled a vaccine factory made from shipping containers that it plans to ship to Africa as assembly kits to ease…
Agilent acquires AI technology to enhance lab productivity
Agilent will integrate the technology into its lab informatics platforms, enabling customers to automate GC/MS data analysis
Assocham organises seventh season of nutraceuticals
Experts from the sector spoke on the title “Nutraceuticals – World’s Future Ceuticals” to encourage modification in lifestyle by…
WHO announces first technology recipients of mRNA vaccine hub with African and European partners
Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia to establish mRNA vaccine production